Welcome to the e-CCO Library Archive!
Disease course, phenotype, and medication use in elderly-onset Crohn's disease patients - A population-based IBD-SL cohort study
S. Jeuring*1, 2, T. Van den Heuvel1, 2, M. Zeegers3, 4, W. Hameeteman1, M. Romberg-Camps5, L. Oostenbrug6, A. Masclee1, 2, D. Jonkers1, 2, M. Pierik1, 2
1Maastricht University Medical Center+, Internal Medicine - Division Gastroenterology-Hepatology, Maastricht, Netherlands, 2Maastricht University Medical Center+, NUTRIM, School for Nutrition, Toxicology and Metabolism, Maastricht, Netherlands, 3University of Birmingham, Public Health, Epidemiology and Biostatistics, Birmingham, United Kingdom, 4Maastricht University Medical Center+, Complex Genetics, Cluster of Genetics and Cell Biology, Maastricht, Netherlands, 5Orbis Medical Center, Gastroenterology and Hepatology, Sittard, Netherlands, 6Atrium Medical Center, Internal Medicine and Gastroenterology, Heerlen, Netherlands
Direct effect of infliximab on intestinal mucosa sustains mucosal healing: Exploring new mechanisms of action
V. Petito1, L. Lopetuso1, E. Stigliano2, V. Arena2, S. Bibbo1, A. Amato3, G. Cammarota1, A. Papa1,4, A. Sgambato2, A. Gasbarrini1, F. Scaldaferri1, 1Catholic University of Sacred Heart, Internal Medicine and Gastroenterology, Rome, Italy, 2Catholic University of Sacred Heart, Pathology, Rome, Italy, 3Catholic University of Sacred Heart, Anesthesiology, Rome, Italy, 4Catholic Universisty, Internal Medicine and Gastroenterology Unit, Complesso Integrato Columbus, Rome, Italy
A. Quaglio1, A. Castilho1, L. Di Stasi1, 1Universidade Estadual Paulista (UNESP), Pharmacology, Botucatu, Brazil
Evaluation of NT-proBNP in Inflammatory Bowel Disease
A. Wacrenier*1, A.-M. Bourgeois2, J. Ausseil2, C. Szymanski3, H. Thiebault1, F. Brazier1, A. Galmiche2, E. Nguyen-Khac1, J.-L. Dupas1, J.-f. Colombel4, M. Fumery1
1Amiens University Hospital, Hepatogastroenterology, Amiens, France, 2Amiens University Hospital, Biochimie, Amiens, France, 3Amiens University Hospital, Cardiology, Amiens, France, 4Icahn School of Medicine at Mount Sinai Hospital, Gastroenterology, New York, NY, United States
Controlling the balance of immunity in colitis: Investigating the roles of intestinal microbiota and dendritic cell migration
S. Borg-Bartolo1, J. McLaughlin2, C. Ballestrem3, S. Cruickshank1, 1University of Manchester, Manchester Immunology Group, Faculty of Life Sciences, Manchester, United Kingdom, 2Salford Royal NHS Foundation Trust, School of Translational Medicine, Manchester, United Kingdom, 3University of Manchester, Wellcome Trust Centre for Cell Matrix Research, Manchester, United Kingdom
J. Wilburn1, S.P. McKenna1, J. Twiss1, M. Ben-L'amri1, K. Kemp2, S. Campbell2, 1Galen Research Ltd, Manchester Science Park, Manchester, United Kingdom, 2Central Manchester University Hospitals NHS Foundation Trust, Gastroenterology, Manchester, United Kingdom
The impact of a value-based health program for inflammatory bowel disease management on healthcare utilization
W.K. van Deen*1, A.B. Ozbay2, M. Skup2, M.G. van Oijen1, A. Centeno1, N. Duran1, P. Lacey1, D. Jatulis3, M. Belman3, E. Esrailian1, D.W. Hommes1
1UCLA Center for Inflammatory Bowel Diseases, Division of Digestive Diseases, University of California, Los Angeles, Los Angeles, United States, 2AbbVie, US Immunology, Nort Chicago, United States, 3Anthem Blue Cross, California, Woodland Hills, United States
Co-administration of 5-aminosalicylic acid to 6-mercaptopurine reduces in vitro hepatotoxicity
M. Broekman, H.M. Roelofs, F. Hoentjen, M. Kerstholt, W.H. Peters, G.J. Wanten, D.J. de Jong, Radboud UMC, Gastroenterology & Hepatology, Nijmegen, Netherlands
C.B. Dias1, L.R. Meirelles2, M. Milanski3, M.L.S. Ayrizono4, A. Coope3, M. Portovedo3, N. Planell5, C.S.R. Coy4, L.A. Velloso3, R.F. Leal1, 1University of Campinas, Colorectal Surgery Unit, Surgery Department. Cell Signalization Laboratory, Internal Medicine Department, Campinas, Brazil, 2University of Campinas, Pathology Department, Campinas, Brazil, 3University of Campinas, Cell Signalization Laboratory, Internal Medicine Department, Campinas, Brazil, 4University of Campinas, Colorectal Surgery Unit, Surgery Department, Campinas, Brazil, 5CIBER-EHD, Department of Gastroenterology and Bioinformatics Platform, Barcelona, Spain
Risk factors for active tuberculosis in patients with inflammatory bowel disease: A case-control study
S. Riestra1, R. de Francisco*2, M. Arias-Guillén3, C. Saro4, M. García-Alvarado5, J.M. Duque6, L. Blanco2, O. Castaño2, F. Muñoz5, I. Pérez-Martínez2, P. Martínez-Camblor7, D. Pérez-Hernández8
1Hospital Universitario Central de Asturias , Gastroenterology, Oviedo, Spain, 2Hospital Universitario Central de Asturias, Gastroenterology, Oviedo, Spain, 3Hospital Universitario Central de Asturias, Respiratory, Oviedo, Spain, 4Hospital de Cabueñes, Gastroenterology, Gijón, Spain, 5Hospital de León, Gastroenterology, León, Spain, 6Hospital San Agustín, Gastroenterology, Avilés, Spain, 7Hospital Universitario Central de Asturias, Oficina de Investigación Biosanitaria, Oviedo, Spain, 8Consejería de Salud, Servicio de Vigilancia Epidemiológica, Oviedo, Spain
Circulating microvesicles in Crohn's disease
E. Gaetani, M. Marcantoni, I. Giarretta, I. Gatto, F. Scaldaferri, F. Del Zompo, L. Laterza, A. Tortora, R. Landi, A. Gasbarrini, R. Pola, Catholic University of Sacred Heart, Internal Medicine and Gastroenterology, Rome, Italy
J. Landy1, E. Ronde2, H. Omar Al-Hassi2, E. Mann2, S. Peake1, P.J. Ciclitira3, R.J. Nicholls4, S.K. Clark5, S. Knight2, A.L. Hart1, 1St Mark's Hospital, IBD Unit, London, United Kingdom, 2Antigen Presentation Research Group, Imperial College, London, United Kingdom, 3St Thomas' Hospital, Gastroenterology, London, United Kingdom, 4Imperial College, Department of Biosurgery and Surgical Technology, London, United Kingdom, 5St Mark's Hospital, Colorectal Surgery, London, United Kingdom